- Shitara, K., Lorenzen, S., Li, J., Bai, Y., Fernández, M. G., Aguilar, M., Shoji, H., Reyes-Cosmelli, F., Peña, Y. R., Corrales, L., Wyrwicz, L., Eyzaguirre, D. A., Pan, Y., Ryu, M.-H., Cohen, D. J., Wainberg, Z. A., Ku, G., Tabernero, J., Van Cutsem, E., … Rha, S. Y. (2025). Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study. Journal of Clinical Oncology. https://doi.org/10.1200/JCO-25-00748 (En premsa)
Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study
on 22 de setembre de 2025
with No hi ha comentaris
Deixa un comentari